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Experimental Study on the Prevention of Vasospasrn Following 
Subarachnoid Hemorrhage by a Thrornboxane A2 
Synthetase Inhibitor, OKY・046
SHIGEAKI 0HSUGI 
Division of Neurosurgery, Brain Research Institute, Niigata University 
(Director: Prof. Dr. RYUICHI TANAKA) 
A disproportion of synthesis of Thromboxane A2 (TXA2) and Prostacyclin (PGI2) might be 
concerned with the occurrence of vasospasm following subarachnoid hemorrhage (SAH). In 
this paper, the prevention of vasospasm by an inhibitor of TXA2 synthetase, OKY-046 was 
studied in the experimental subarachnoid hemorrhage of dog・
The experimental SAH was produced by an intracisternal injection of 5 ml fresh autologous 
arterial blood through the optic canal. The changes of the caliber of the basilar artery were 
followed by angiography after SAH. Platelet aggregation, activated partial thromboplastin 
time (APTT), prothrombin time (PT) and fibrinogen were examined 3 days after SAH. Local 
cerebral blood flow (LCBF) and thromboxane B2 (TXB2) and 6 keto-prostaglandin Fiα （6 keto-
PGF1α） in the plasma of the jugular vein were sequentially studied for 48 hours after SAH. 
These parameters were studied in 2 groups: Continuous intravenous infusion of OKY-046 of 
100 μ,g/kg/min or partly of 10 μ,g/k創立山wasperformed in the treatment group. Normal saline 
was infused to the control group. LCBF was measured by hydrogen clearance method, and 
TXB2 and 6 ketoPGF1a were measured by radioimmunoassay. 
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The vasospasm of the basilar artery was evaluated by measuring the reduction of the caliber 
on the angiogram, and the degree of the vasospasm 3 days after SAH was 36. 7土4.7% reduction 
in the control group and 16.5土3.8%reduction in the treatment group. 
There was a significant difference between the two groups. There was a slight decrease in 
the function of platelet aggregation in the control group, but coagulations (APTT、PT、fibrinogen)
were similar in both groups. TXB2 in the plasma of the jugular vein increased markedly 1 to
6 hours after SAH in the control group, whereas it was remarkably inhibited in the treatment 
group. On the other hand‘6 ketoPGF1αincreased about 3 hours after SAH in both groups, 
but no signi五cantdifference was found between them. LCBF in the control group decreased 
after SAH, but increased significantly in the treatment group 2 hours after SAH. 
These results indicate that an increase of synthesis of TXA2 plays an important role in the 
evolution of cerebral vasospasm following SAH, and that an inhibitor of TXA2 synthetase may 



















































[p戸（lH－イミダゾー ノレー 1－イ JレメチJレ）フェー ル］ー 2－プ
ロペン般ナトリウム） 100 μg/Kg/minの持続静注群
2) 同様に OKY046, lOμg/Kg/minの持続静注
群






度 10-•M の ADP を使用し，最大凝集率を測定した．












成前，作成後1時間， 2時間， 3時間， 6時間， 12時
間， 24時間， 48時間にそれぞれ測定し検討した（但し
LCBFは12時間後まで）。


















100 μg/Kg/min投与群では16.5±3. 8／ぢ， OKY-046,
10 μg/Kg/min投与群では22.7±2. 35'ちであり，対照





















は 13.7土0.5 secから 14.9±0. 6 secへ， OKY046, 
100 μg/Kg/min投与群では 14.3±0. 4 secから 17.1
土0.6 secへ， 10μg/Kg/min投与群では 14.8±0. 5 





% change of Basilar Artery Diameter 
Fig. 1. The changes of the caliber of the basilar artery 3 days after subarachnoid hemorrhage. 
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自 12 24 48(hrs) 


































。ー-0: Control n=9 













群では7.2土o.2 secから 7.3±0. 3 secへ， OKY-046,
100 μ,g/Kg/min投与群では 7.6土0.3 secから 7.3±




群では 232.0±40. 9 mg/dlから 549.6土44.4mg/dl
へ， OKY046, 100 μ,g/Kg/min投与群では 235.9土
57. 4mg/dlから 506.6士61.6mg/dlへ， 10μ,g/Kg/ 
min投与群では 270.2±10. 2 mg/dlから 628.0土12.9
。
3 
Days after SAH 
Fig. 4・a.
0----0 : Control n=9 








・－－・.OKY 046 1 OOμg/kg/min n=8 













。3 Days after SAH 
Effect of the intravenous administration of 
OKY-046 on the platelet aggregation 3 days 













。－－0・Control n~9 ・－・ OKY-0461 OQμg/kg/m1n n-8 
・一一個 OKY-046 1 Qμg/kg/min n=5 200 
0 
0 3 
Days after SAH 
Fig. 4-c. 
Fig. 4. Effect of the intravenous administration of 
OKY-046 on the coagulation functions 3 days 








1. 81土0.58 ng/dl, 1. 41土0.30 ng/dlであり， OKY
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Fig. 7. The changes of LCBF in the posterior parietal cortex after subarachnoid blood injection. 
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